市场调查报告书
商品编码
1567803
2030 年亚太地区中胚层疗法市场预测 - 区域分析 - 按产品类型、适应症和最终用户Asia Pacific Mesotherapy Market Forecast to 2030 - Regional Analysis - by Product Type, Indication, and End Users |
2022年亚太地区中胚层疗法市场估值为1.0691亿美元,预计2030年将达到2.2442亿美元;预计2022年至2030年复合年增长率为9.7%。
技术进步带来的舒适度、效率和结果的改善推动了亚太地区中胚层疗法市场的发展
自动注射设备、奈米技术和无针美塑疗法等技术发展改善了治疗效果,提高了患者的舒适度,并提高了美塑疗法的效率。这些技术的引入彻底改变了中胚层疗法产品的交付方式。例如,自动注射设备采用先进技术来精确管理注射深度、速度和体积,确保药物准确地放置在皮肤中。自动注射设备提高了中胚层疗法的均匀性和功效,同时降低了人为错误的风险,从而改善了治疗结果。同样,奈米技术使得特定美塑疗法配方的开发成为可能,该配方使用奈米尺寸的颗粒来改善活性成分在皮肤上的分布。例如,脂质体是一种基于脂质的囊泡,可以封装药用物质并将其运输到特定位置,从而提高其吸收和生物利用度。这些改进的递送技术提供了更高的成分渗透性、更高的治疗功效以及活性化合物的持续释放,从而为患者带来长期效果。
无针美塑疗法采用超音波技术。这种类型的中胚层疗法是将药妆品和注射化合物输送到皮肤中层(中真皮)的安全方法。利用温和的低频电流与超音波结合,将天然精华液透过皮肤表面下的小通道深入细胞层面。抗氧化剂、维生素、胜肽和透明质酸等天然元素有助于使皮肤看起来更健康、更光滑、肤色更年轻。因此,美塑疗法技术的进步在推动美塑疗法市场的成长方面发挥着重要作用。
亚太地区中胚层疗法市场概况
预计2022年至2030年,亚太地区美塑疗法市场将以高复合年增长率成长。在中国,中胚层疗法在各公立和私立医院中获得了巨大的关注。另一方面,随着医疗保健的持续发展以及人们在此类手术上的支出意愿的增加,预计印度市场在未来几年将加快步伐。同时,随着美容旅游业的不断发展,韩国的中胚层疗法市场可能会蓬勃发展。中国拥有亚太地区最大的美塑疗法市场。蓬勃发展的美容产业、皮肤病的高发病率、人们对美容手术以增强美学吸引力的意识不断增强,以及对微创手术(皮肤再生和增强)的需求不断增加,推动了该国市场的成长。据上海市人民政府称,中国约有70%的人患有湿疹、带状疱疹等皮肤问题。另据报导,湿疹、皮肤搔痒、带状疱疹是老年族群中诊断的前三位皮肤病。湿疹和带状疱疹可以透过美塑疗法治疗。
亚太地区中胚层疗法市场收入及2030年预测(百万美元)
亚太地区中胚层疗法市场区隔
亚太地区中胚层疗法市场按产品类型、适应症、最终用户和国家分类。
根据产品类型,亚太地区美塑疗法市场分为美塑疗法解决方案套件、美塑疗法设备、美塑疗法填充套件、美塑疗法化学换肤和抗衰老面膜。中胚层疗法解决方案套件细分市场在 2022 年占据最大的市场份额。
从适应症来看,亚太地区中胚层疗法市场分为抗衰老和皱纹治疗、脸部年轻化、减肥、脱髮、妊娠纹以及痤疮和疤痕治疗。 2022年,抗衰老和皱纹治疗设备领域占据亚太美塑疗法市场的最大份额。
根据最终用户,亚太地区美塑疗法市场分为皮肤科诊所、美容诊所、医院等。 2022年,皮肤科诊所占据亚太美塑疗法市场的最大份额。
依国家划分,亚太地区美塑疗法市场分为中国、日本、印度、韩国、澳洲和亚太其他地区。 2022年,中国在亚太美塑疗法市场占有率中占据主导地位。
Koru Pharma Co Ltd、Institute BCN Esthetics SL、Mesoskinline ApS、高露洁棕榄 Co、Toskani SL、Mesoestetic E-Commerce SL、Galderma SA、Derm Beauty International Sdn Bhd、Mesotech Srl 和 Ostar Beauty Sci-Tech Co Ltd 等亚太美塑疗法市场的领先公司。
The Asia Pacific mesotherapy market was valued at US$ 106.91 million in 2022 and is expected to reach US$ 224.42 million by 2030; it is estimated to register a CAGR of 9.7% from 2022 to 2030.
Improvements in Comfort, Efficiency, and Outcomes with Technological Advancements Boost Asia Pacific Mesotherapy Market
Technological developments such as automated injection devices, nanotechnology, and no-needle mesotherapy have improved treatment outcomes, enhanced patient comfort, and increased efficiency in mesotherapy treatments. The introduction of these technologies has revolutionized the way mesotherapy products are delivered. For instance, automated injection devices use advanced technology to precisely manage the depth, pace, and volume of injections, ensuring that the drugs are accurately placed in the skin. Automated injection devices improve the uniformity and efficacy of mesotherapy treatments, along with lowering the risk of human errors, thereby improving the outcomes. Similarly, nanotechnology has enabled the development of specific mesotherapy formulations that use nano-sized particles to improve active ingredient distribution to the skin. Liposomes, for instance, are lipid-based vesicles that can encapsulate medicinal substances and transport them to specific locations, thereby improving their absorption and bioavailability. These improved delivery technologies provide higher ingredient penetration, increased therapy efficacy, and sustained release of active compounds, resulting in longer-term results in patients.
No-needle mesotherapy treatments use ultrasonic technology. This type of mesotherapy is a safe method of delivering cosmeceutical and injectable compounds into the middle layer (mesodermis) of the skin. Natural serums are carried deep into the cellular level via small channels under the skin surface by utilizing a mild low-frequency current in conjunction with ultrasound. Natural elements such as antioxidants, vitamins, peptides, and hyaluronic acid help make the skin appear healthier, smoother, toned, and youthful. Thus, advancements in mesotherapy technology play a significant role in driving the growth of the mesotherapy market.
Asia Pacific Mesotherapy Market Overview
The Asia Pacific mesotherapy market is expected to grow at a high CAGR from 2022 to 2030. The market in China and Japan is expected to grow at a fast pace due to the increasing popularity of mesotherapy and growing medical tourism. In China, mesotherapy is gaining significant traction in various public and private hospitals. On the other hand, the market in India is expected to pick pace in the coming years with ongoing developments in healthcare and increasing people's willingness to spend on such procedures. Meanwhile, the mesotherapy market in South Korea is likely to flourish with the increasing cosmetic tourism. China holds the largest mesotherapy market in Asia Pacific. The burgeoning aesthetic industry, high prevalence of skin diseases, growing awareness of cosmetic procedures to enhance aesthetic appeal, and increasing demand for minimally invasive procedures (for skin rejuvenation and enhancement) propel the market growth in this country. According to the Shanghai Municipal People's Government, ~70% of people in China suffer from skin problems, such as eczema and shingles. It is also reported that eczema, skin pruritus, and shingles are the top 3 skin diseases diagnosed in the elderly population. Eczema and Shingles can be treated through mesotherapy.
Asia Pacific Mesotherapy Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Mesotherapy Market Segmentation
The Asia Pacific mesotherapy market is categorized into product type, indication, end users, and country.
Based on product type, the Asia Pacific mesotherapy market is segmented into mesotherapy solution kits, mesotherapy devices, mesotherapy fillers kits, mesotherapy chemical peels, and anti-ageing masks. The mesotherapy solution kits segment held the largest market share in 2022.
In terms of indication, the Asia Pacific mesotherapy market is segmented into anti-ageing & wrinkle treatment, facial rejuvenation, fat loss, hair loss, stretch marks, and acne & scar treatment. The anti-ageing & wrinkle treatment devices segment held the largest share of Asia Pacific mesotherapy market in 2022.
Based on end users, the Asia Pacific mesotherapy market is categorized into dermatology clinics, cosmetic clinics, hospitals, and others. The dermatology clinics segment held the largest share of Asia Pacific mesotherapy market in 2022.
Based on country, the Asia Pacific mesotherapy market is categorized into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific mesotherapy market share in 2022.
Koru Pharma Co Ltd, Institute BCN Esthetics SL, Mesoskinline ApS, Colgate Palmolive Co, Toskani SL, Mesoestetic E-Commerce SL, Galderma SA, Derm Beauty International Sdn Bhd, Mesotech Srl, and Ostar Beauty Sci-Tech Co Ltd are some of the leading companies operating in the Asia Pacific mesotherapy market.